LEPTIN - ANVISA Registration 10230730176
Access comprehensive regulatory information for LEPTIN in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10230730176 and manufactured by DRG INTERNATIONAL, INC.. The registration is held by NL COMรRCIO EXTERIOR LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including DRG INSTRUMENTS GMBH, LDN- LABOR DIAGNOSTIKA NORD GMBH & CO, KG, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
10230730176
25351638005202274
52541273000147
Company Information
Dates and Status
Jan 16, 2023
VIGENTE
09/18/2025 19:00:01
LEPTINA
DRG LEPITINA โ ELISA
DRG INTERNATIONAL, INC.
80680420084
May 29, 2023
LEPTINA
Leptin ELISA
LDN- LABOR DIAGNOSTIKA NORD GMBH & CO, KG
81086830054
Feb 06, 2023
LEPTINA
Leptina ELISA
EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG
10338930269
Sep 09, 2021
LEPTINA
LEPTIN
DIAGNOSTICS BIOCHEM CANADA INC
10300390556
May 20, 2019
LEPTINA
Leptina
EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDA
10338930208
Feb 18, 2019

